436 The Prospective Epidemiologic Risk Factor (PERF I) Study: A novel prognostic serum biomarker reflecting type I collagen degradation is associated with tumor burden. (September 2015) - Kehlet, S.N.; Bager, C.L.; Willumsen, N.; Dragsb, K.; Neergaard, J.S.; Hansen, H.B.; Bay-Jensen, A.C.; Oersnes-Leeming, D.J.; Christiansen, C.; Karsdal, M.A.